ENTOURAGE HEALTH CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.01 CAD | 0.00% |
|
-33.33% | -33.33% |
| Jan. 31 | Entourage Health Corp. Announces Resignation of Lu Cacioppo from its Board of Directors | CI |
| 2023 | Entourage Health Provides Corporate Update | MT |
| Sales 2021 | 42.27M 30.7M | Sales 2022 | 40.89M 29.7M | Capitalization | 6.13M 4.46M |
|---|---|---|---|---|---|
| Net income 2021 | -78M -56.64M | Net income 2022 | -123M -89.32M | EV / Sales 2021 | 2.56 x |
| Net Debt 2021 | 83.94M 60.96M | Net Debt 2022 | 125M 91.11M | EV / Sales 2022 | 3.22 x |
| P/E ratio 2021 |
-0.25
x | P/E ratio 2022 |
-0.05
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 79.45% |
More Fundamentals
* Assessed data
More news
Latest transcript on Entourage Health Corp.
More press releases
| 1 week | -33.33% | ||
| 6 months | -33.33% | ||
| Current year | -33.33% |
1 week
0.01
0.02
1 month
0.010.02
Current year
0.010.02
1 year
0.010.03
3 years
0.010.33
5 years
0.012.00
10 years
0.013.25
| Managers | Title | Age | Since |
|---|---|---|---|
George Scorsis
CEO | Chief Executive Officer | - | 19-12-22 |
Peter Blecher
FOU | Founder | - | - |
Vaani Maharaj
DFI | Director of Finance/CFO | - | 22-05-03 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bruce Croxon
BRD | Director/Board Member | - | 20-07-23 |
George Scorsis
CEO | Chief Executive Officer | - | 19-12-22 |
Gail Paech
BRD | Director/Board Member | 76 | 17-04-12 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 0.01 | 0.00% | 35,947 |
| 24-04-17 | 0.01 | -33.33% | 13,110 |
| 24-04-16 | 0.015 | +50.00% | 17,625 |
| 24-04-15 | 0.01 | -33.33% | 56,465 |
| 24-04-12 | 0.015 | 0.00% | 770,279 |
Delayed Quote Toronto S.E., April 18, 2024 at 02:15 pm EDT
More quotes
Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio includes Color Cannabis, Saturday Cannabis and now Dime Bag and Syndicate, sold across eight provincial distribution agencies.
Sector
Pharmaceuticals
Calendar
2024-04-30
- Q4 2023 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.33% | 2.24M | |
| +26.32% | 3.74B | |
| +129.49% | 2.18B | |
| +68.25% | 55.17M | |
| +265.38% | 54.09M |
- Stock Market
- Equities
- ENTG Stock
